This bill changes prior authorization rules for health insurance plans to improve access to ongoing treatments. It requires that prior authorizations for chronic conditions or long-term care remain valid for the full treatment duration or one year (whichever is longer), and prohibits renewal more frequently than once every five years for treatments lasting over a year. It also prevents health plans from restricting coverage for previously approved medications within 90 days of switching plans, unless the patient's condition changes, and mandates 90 days' notice before any coverage restriction. The bill directly affects patients with chronic conditions and health insurance carriers in Maine.
This bill exempts certain over-the-counter (OTC) medicines from Maine's sales tax starting January 1, 2026. It applies to FDA-approved OTC medicines meeting specific labeling requirements, including antacids, contraceptive products, allergy medications, eye/ear/nose treatments, and opioid antagonists. The exemption covers medicines sold directly to consumers without a prescription, but excludes cannabis products. This change affects Maine residents purchasing these specific OTC health products, reducing their out-of-pocket costs for essential medications.
LD 182 requires Maine's Department of Health and Human Services to set MaineCare reimbursement rates for Maine Veterans' Homes on a per-resident daily basis. This directly affects veterans' facilities (including nursing homes and residential care facilities operated by Maine Veterans' Homes) and ensures MaineCare covers the portion of their operating costs tied to residents receiving MaineCare benefits. The bill mandates annual inflation adjustments to these rates and allows the department to use data from other states or hire third parties to establish them. It does not change eligibility but standardizes how costs for covered residents are calculated and reimbursed.
This resolve authorizes the final adoption of specific regulatory provisions concerning the prescriptive authorities and collaborative relationships for naturopathic doctors in Maine. The Department of Professional and Financial Regulation submitted these rules to the legislature after the standard filing deadline, which required a special legislative action to approve them. By passing this measure, the state legislature grants the necessary approval for these professional practice standards to take effect immediately.
LD 82 extends a permanent presumption in Maine's workers' compensation law that automatically considers post-traumatic stress disorder (PTSD) work-related for certain public safety workers. This applies to law enforcement officers, corrections officers, E-9-1-1 dispatchers, firefighters, and emergency medical services personnel diagnosed with PTSD. Currently, this presumption was set to expire on October 1, 2025, but the bill removes that expiration date. As a result, these workers no longer need to prove their PTSD was caused by job duties to qualify for compensation benefits.
LD 1266 requires Maine's Attorney General to form a working group to create a plan expanding access to adult drug, family, and veterans treatment courts statewide. The group must include stakeholders like courts, corrections, health departments, prosecutors, and advocacy organizations to ensure every county has access to these specialty courts for defendants whose criminal involvement relates to substance use disorders. The working group must submit its recommendations and suggested legislation to the Judiciary Committee by January 1, 2026. This resolve does not change current law but directs a study to improve access to treatment-based court options.
This bill repeals Maine's mandatory paid family and medical leave program, making participation voluntary instead. It limits the program to employers with 50 or more employees and requires the Department of Labor to refund all contributions made under the previous mandatory system to both employers and employees by June 2026. Unappropriated funds from the leave program must be transferred to the state's general fund by June 30, 2026. The changes take effect retroactively to October 25, 2023.
This bill exempts agricultural employers and employees from Maine's Paid Family and Medical Leave Benefits Program, directly affecting those working in agriculture as defined by state and federal law. It requires the Department of Labor to refund all contributions paid by agricultural employers and self-employed individuals to the program, including any premiums deducted from employee wages that must be returned to workers. The refunds apply retroactively to October 25, 2023, when contributions began. The legislation aims to halt economic harm to the agricultural sector by eliminating these financial obligations.
LD 406 repeals Maine's paid family and medical leave program and requires the state to refund all contributions collected from employers and employees since January 1, 2025. The bill stops future contributions and mandates immediate refunds to taxpayers to address economic harm to businesses and workers. As an emergency measure, it bypasses Maine's standard 90-day legislative waiting period for immediate effect. This directly affects Maine employers and employees who had begun paying into the program in 2025.
LD 219 limits certified hypodermic apparatus exchange programs in Maine to a one-for-one exchange. The bill requires participants to return one used needle to receive one new needle from the program. This change directly affects participants in Maine's certified needle exchange programs and the Maine Center for Disease Control and Prevention, which administers these programs under the updated law. The policy change modifies existing law to ensure participants receive only one new needle per needle they exchange.
